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Cryopreservation is a method commonly used to store human blood that also has numerous other advantages. The cryopreservation of hut
man cells for longtterm storage has a vital advantage, 
especially in a setting of bone marrow transplantation 
and blood transfusion. Frozen lymphocytes can be used 
for tissue typing, for monitoring celltmediated immut
nity, and for various immunological tests.1t4 Studies ret
quiring a lymphocytetmediated response for sequential 
analysis during the course of the disease require the use 
of cryopreserved lymphocytes.5 Immunophenotyping 
is crucial for diagnosis and risk stratification of acute 
leukemia. Although many studies have addressed the 
cryopreservation of lymphocytes and its value in imt
munological studies,6t10 not many have addressed the 
use of cryopreservation for different blasts cells, with 
the impact of cryopreservation on blast viability and 
the expression of various antigens.10,11 We report a 
modified cryopreservation method for longtterm stort
age of leukemic blast cells with a study of the effect of 
this cryopreservation on viability and antigen exprest
sion.
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METHODS
A total of 20 newly diagnosed cases of acute leukemia 
were collected from January to April 2007 of which 9 
cases were acute pretB lymphoblastic leukemia (Pret 
BtALL), 6 cases were acute myeloblastic leukemia 
(AML), 4 cases were Ttcell acute lymphoblastic leuket
mia (TtALL) and 1 case was acute biphenotypic leut
kemia (ABL). Residual anticoagulated bone marrow or 
peripheral blood were frozen and processed as below. 
Freezing Methodology. Residual samples from imt
munophenotyping were washed twice using cold Hanks 
Balanced Salt Solution HBSS (SAFC Biosciences, 
Lenexa, Kansas, USA) after which the cell count was 
adjusted to 5t12×109/L. A 10% dimethyl sulfoxide 
(DMSO) freezing solution was prepared by mixt
ing fresh and cold 10 mL of HBSS with 6 mL of fetal 
calf serum and 1.8 mL of DMSO. The freezing media 
was then placed on ice. Six aliquots were labeled week 
1 through week 6 using cryogenic vials. Equal volumes 
of blood sample and chilled freezing medium (500 µL 
blood+500 µL freezing medium) was added to each of 
the vials. This gave a final concentration of 5% of the 
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freezing media. The vials were mixed and quickly placed 
in the –70°C freezer. After every week, frozen samples 
were thawed immediately and rapidly at 37°C and then 
washed twice using cold HBSS and filtered. Frozen cells 
then were stained with different monoclonal antibodies.
Immunophenotyping methodology. The following 
monoclonal antibodies were used: Ttcell markers CD1at
PE (coulter), CD2tPE (BD), CD3tFITC (B.D), CD4t
APC(BD), CD8tPE(BD), CD7tFITC (BD), CD5t
FITC(BD), TCR((tFITC(BD), TCR((tPE(BD) where 
as Btcell markers included CD10tFITC(Coulter), CD19t
APC(BD), CD20tPE(BD), CD22tAPC(BD), Kappat
FITC(BD), LambdatPE(BD), IgGtFITC(Biosource), 
IgMtFITC(Biosource). The myelomonocytic markers 





Frequency of antigen 
expression at presentation
Frequency of antigen expression 
at 4 weeks
Frequency of antigen 
expression at 6 weeks
pre-b All 9 CD10          9/9 9/9 9/9
  CD19          9/9 9/9 9/9
  CD79a        5/9 5/5 5/5
  CD34          8/9 8/8 8/8
  TdT             9/9 9/9 9/9
  HlA-Dr      9/9 9/9 9/9
  CD45          7/9 6/9 6/9
AMl 6 CD7           2/6 2/2 2/2
  CD13         5/6 5/5 5/5
  CD33         6/6 6/6 6/6
  CD117       5/6 5/5 5/5
  CD34         2/6 2/2 2/2
  MpO          4/6 3/6 3/6
  HlA-Dr     6/6 6/6 6/6
  CD45         6/6 6/6 6/6
T-All 4 CD2           4/4 4/4 4/4
  CD3           4/4 4/4 4/4
  CD5           4/4 4/4 4/4
  CD7           4/4 4/4 4/4
  TdT            3/4 3/4 3/4
  CD45         4/4 4/4 4/4
Abl 1 CD7           1/1 1/1 1/1
  CD19         1/1 1/1 1/1
  CD33         1/1 1/1 1/1
  CD34         1/1 1/1 1/1
  CD79a       1/1 1/1 1/1
  CD117       1/1 1/1 1/1
  TdT            1/1 0/1 0/1
  HlA-Dr     1/1 1/1 1/1
  CD45         1/1 1/1 1/1
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used were CD14tFITC (BD), CD13tPE (BD), CD33t
PE (BD), CD64tFITC (BD), CD65tFITC (BD), 
CD117tPE (BD), CD15tFITC (BD), and CD11btPE 
(BD). Monoclonal antibodies against cytoplasmic and 
nuclear antigens were used MPOtFITC (Coulter), TdTt
FITC “polyclonal” (Coulter), CD79atPE (Coulter), 
CD3tFITC (Coulter). Additional monoclonal antibodt
ies used were CD45tPerCP (BD), HLAtDRtFITC 
(BD), CD34tAPC (BD), NG2tPE (Coulter), CD11ct
PE (BD), CD9tFITC (BD), CD56tAPC (BD), CD61t
FITC (BD) to identify megakaryocytes, CD235atFITC 
(Coulter) and CD71tFITC (BD) to identify erythroid 
precursors. Cell viability was measured by staining the 
cells using 7tamino actinomycin D (7tAAD) dye.
After the second wash the cells were filtered and the 
count adjusted to 0.5t1×109/L of which a 50 µL was 
placed in each tube and incubated with the appropriate 
combination of monoclonal antibodies for 15t20 mint
utes in the dark (room temperature). Once the incubat
tion period was finished the cells were washed one more 
time as above. The cells were then resuspended in 0.5 
mL of 1% paraformaldehyde and stored in the refrigerat
tor till time of analysis. 
For staining of the cytoplasmic and nuclear antigens 
the IntraPrep Permeabilization Reagent kit (Beckman 
Coulter, Fullerton, CA, USA) was used, strictly followt
ing the recommendations of the manufacturer. Data act
quisition was performed using a FACSCalibur system 
equipped with two lasers and Cell Quest Pro software 
(Becton Dickinson, San Juan, CA, USA) where a minit
mum of 10 000 events/tube were acquired. Instruments 
were daily calibrated using CALIBRITE beads (Becton 
Dickinson, San Juan, CA, USA) and two levels (normal 
and low) of controls using CD3/CD8/CD45/CD4 
and CD3/CD16+56/CD45/CD19 run daily to ensure 
consistency in the functions of the instrument. Data 
analysis was performed using Cell Quest Pro software 
and the blast cells were gated on using CD45 vs. SSC 
technique. The following criteria were used to score the 
blast population: negative <20% and positive: >20% of 
the gated blasts.
RESULTS
Table 1 shows frequency of antigen expression for each 
leukemia at different time intervals. While all cases 
had viability over 75% at presentation, 33/36 (91%) 
of pretB ALL, 14/16 (88%) of TtALL, 24/24 (100%) 
AML and 4/4 (100%) biphenotypic leukemia aliquots, 
respectively, had viability over 75% by 4 weeks. The vit
ability continued to be reliably above 75% when aliquots 
were tested at 6 weeks from cryopreservation. The flow 
cytometry analysis of the six aliquots for each case demt
onstrated good preservation of various antigen exprest
sion compared to the original fresh samples results with 
no major change.
DISCUSSION
Preservation of human cells such as blood and bone 
marrow cells has become increasingly important in both 
basic research and clinical medicine. Cryopreserved cells 
proved to be excellent controls for determining the dayt
totday variability and for selecting optimum conditions 
for laboratory tests in the clinical immunology laborat
tory.4,10 Cryopreservation of human mononuclear cells 
has been used for quality control materials in clinical 
immunology.12 In multicenter studies, the precision 
and accuracy of complex immunologic assays could 
be greatly improved if specimens obtained at multiple 
sites could be analyzed in a single, highly skilled laborat
tory, which requires adequate preservation of the cells. 
Riemann et al had demonstrated in multicenter AIDS 
clinical trials the feasibility of cryopreserving peripheral 
blood mononuclear cells for immunophenotyping and 
functional testing.13 Although it had been shown in a 
number of studies that cryopreservation has some delt
eterious effect on the viability of cells and antigen ext
pression14,15 that we did not have in the method we are 
presenting here. A number of methods were introduced 
for cryopreservation, with different effects on cell funct
tion and antigen preservation.5,13t18 Use of DMSO is 
considered the method of choice as it is easy, rapid and 
effective. The effect of various concentrations of DMSO, 
the composition of the medium, and other parameters 
were investigated in several trials to work out optimal 
conditions for freezing human lymphocytes. Although 
the ideal concentration of DMSO has been extensively 
studied, concentrations as low as 5% have resulted in a 
good recovery of cryopreserved lymphocytes.5 However, 
this was complemented with gradual freezing at 2°C per 
minute.
In this study, we validated a simple method that uses 
a concentration of 10% DMSO when mixed with freezt
ing media and added to an equal volume of blood that 
can be frozen immediately. In a retrospective analysis of 
specimens obtained at presentation of acute leukemia 
and cryopreserved by this method, we found that the 
viability had been preserved in more than 88% of the 
cells with variability between the types of leukemia. The 
myeloid leukemia had better viability than the lymphoid 
leukemia. Both B and T lymphoid cells had shown some 
degree of decrease in viability with no significant change 
in antigen expression. These results are somewhat comt
parable to that reported by Thiry et al for Btcell chronic 
lymphocytic leukemia19 and Romue et al for lymphocyte 
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Immunophenotyping of acute leukemias is the cort
nerstone of diagnosis and very important in risk stratit
fication and followtup post therapy. In many situations 
the leukemia diagnosis needs to be done in a remote 
center, which necessities transfer of samples.
This project was aimed at determining the applicat
bility of using cryopreservation in diagnosis of acute 
leukemia with the intention to use cryopreserved leut
kemic blasts for further studies, especially minimal ret
sidual disease detection. It will also provide a good tool 
for quality control for leukemia studies.
